#ELOX Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-to-present-at-the-3rd-annual-guggenheim-89abkts3vhpl.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-to-present-at-the-3rd-annual-guggenheim-89abkts3vhpl.html?utm_source=stocktitan-bluesky&utm_medium=social
www.stocktitan.net
November 2, 2026 at 9:15 PM
#ELOX Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-to-present-at-the-3rd-annual-guggenheim-89abkts3vhpl.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-to-present-at-the-3rd-annual-guggenheim-89abkts3vhpl.html?utm_source=stocktitan-bluesky&utm_medium=social
#ELOX Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation…
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-fda-clearance-of-investigational-new-hnw3zpuia1hg.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-fda-clearance-of-investigational-new-hnw3zpuia1hg.html?utm_source=stocktitan-bluesky&utm_medium=social
Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation ADPKD
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 29, 2026 at 12:00 PM
#ELOX Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation…
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-fda-clearance-of-investigational-new-hnw3zpuia1hg.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-fda-clearance-of-investigational-new-hnw3zpuia1hg.html?utm_source=stocktitan-bluesky&utm_medium=social
🚨 $ELOX
Germano Geno J (Insider) reported special transactions (Non-P/S).
Germano Geno J (Insider) reported special transactions (Non-P/S).
SEC Filing: ELOX
Click to view the official SEC document.
www.sec.gov
October 21, 2026 at 11:33 PM
🚨 $ELOX
Germano Geno J (Insider) reported special transactions (Non-P/S).
Germano Geno J (Insider) reported special transactions (Non-P/S).
🚨 $ELOX
Germano Geno J (Insider) filed Form 3 reporting no initial stock ownership.
Germano Geno J (Insider) filed Form 3 reporting no initial stock ownership.
SEC Filing: ELOX
Click to view the official SEC document.
www.sec.gov
October 21, 2026 at 11:33 PM
🚨 $ELOX
Germano Geno J (Insider) filed Form 3 reporting no initial stock ownership.
Germano Geno J (Insider) filed Form 3 reporting no initial stock ownership.
Dilution watch, filings Thu Oct 22 to Fri Oct 23 (names we alerted in the last 90 days): $AMOD priced an offering; $ELOX priced an offering; $PMI filed a new S-3; $JAGX filed a new S-3. Not financial advice.
https://momometer.com/go/bluesky/dilution_watch
https://momometer.com/go/bluesky/dilution_watch
October 23, 2026 at 11:15 AM
Dilution watch, filings Thu Oct 22 to Fri Oct 23 (names we alerted in the last 90 days): $AMOD priced an offering; $ELOX priced an offering; $PMI filed a new S-3; $JAGX filed a new S-3. Not financial advice.
https://momometer.com/go/bluesky/dilution_watch
https://momometer.com/go/bluesky/dilution_watch
#ELOX Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Sriniv…
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-finalizes-52-week-phase-2-express-study-design-p4rvrzo7kysq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-finalizes-52-week-phase-2-express-study-design-p4rvrzo7kysq.html?utm_source=stocktitan-bluesky&utm_medium=social
Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 20, 2026 at 1:32 PM
#ELOX Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Sriniv…
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-finalizes-52-week-phase-2-express-study-design-p4rvrzo7kysq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-finalizes-52-week-phase-2-express-study-design-p4rvrzo7kysq.html?utm_source=stocktitan-bluesky&utm_medium=social
🔭 Arena watchlist · Tue Oct 20
Early movers our paper traders are watching: WORX +50%, SAIQ +39%, NCPL +17%, XCUR +12%, ELOX +11%. Watch them call entries and exits live, with the Scout reading the tape out loud.
https://suggestionbox.live/arena/day/
Paper trades, not advice.
Early movers our paper traders are watching: WORX +50%, SAIQ +39%, NCPL +17%, XCUR +12%, ELOX +11%. Watch them call entries and exits live, with the Scout reading the tape out loud.
https://suggestionbox.live/arena/day/
Paper trades, not advice.
October 20, 2026 at 12:46 PM
🔭 Arena watchlist · Tue Oct 20
Early movers our paper traders are watching: WORX +50%, SAIQ +39%, NCPL +17%, XCUR +12%, ELOX +11%. Watch them call entries and exits live, with the Scout reading the tape out loud.
https://suggestionbox.live/arena/day/
Paper trades, not advice.
Early movers our paper traders are watching: WORX +50%, SAIQ +39%, NCPL +17%, XCUR +12%, ELOX +11%. Watch them call entries and exits live, with the Scout reading the tape out loud.
https://suggestionbox.live/arena/day/
Paper trades, not advice.
Trixie bettelt bei Elox um ein ELEKTROAUTO (sic!)
Kann man sich nicht ausdenken.
Kann man sich nicht ausdenken.
October 9, 2026 at 2:24 PM
Trixie bettelt bei Elox um ein ELEKTROAUTO (sic!)
Kann man sich nicht ausdenken.
Kann man sich nicht ausdenken.
I doubt if Elox can even spell science, let alone do science.
October 8, 2026 at 9:38 PM
I doubt if Elox can even spell science, let alone do science.
#ELOX Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-first-patients-dosed-in-phase-2b-tjjxrysrqn4o.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-first-patients-dosed-in-phase-2b-tjjxrysrqn4o.html?utm_source=stocktitan-bluesky&utm_medium=social
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
Eloxx Pharmaceuticals (ELOX) has dosed the first two patients in the EXACT Study, a Phase 2b trial of exaluren in nonsense mutation Alport syndrome (NMAS).The study is evaluating exaluren in patients whose Alport syndrome is driven by nonsense mutations, a group for which there is currently no FDA-approved therapy targeting the underlying genetic cause. The company expects topline data from the initial 16-week placebo-controlled portion of the study in mid‑2027, with a final readout anticipated by the end of 2027. Company leadership and external clinical experts describe this as an important step for an underserved patient population that can progress to kidney failure in early adulthood.
www.stocktitan.net
September 11, 2026 at 11:30 AM
#ELOX Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-first-patients-dosed-in-phase-2b-tjjxrysrqn4o.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-announces-first-patients-dosed-in-phase-2b-tjjxrysrqn4o.html?utm_source=stocktitan-bluesky&utm_medium=social
#ELOX Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-reports-second-quarter-2026-financial-results-cso3v8va1rvv.html
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-reports-second-quarter-2026-financial-results-cso3v8va1rvv.html
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Eloxx Pharmaceuticals (Nasdaq: ELOX) reported second quarter 2026 results and a major strengthening of its capital position following a completed underwritten public offering with $66.0 million in gross proceeds and uplisting to the Nasdaq Capital Market. Net proceeds were approximately $58.3 million, contributing to $62.0 million in cash and cash equivalents as of June 30, 2026, which the company expects will fund operations into mid‑2028 and through data readouts for exaluren in Alport syndrome and ADPKD.Eloxx obtained FDA clearance to proceed with a Phase 2b trial of exaluren in nonsense mutation Alport syndrome, targeted to start in the third quarter of 2026, with topline 16‑week data expected by mid‑2027. Exaluren has orphan drug designation for Alport syndrome in the US and EU, and in July 2026 the European Commission granted orphan designation for exaluren in ADPKD. A Phase 2 ADPKD trial is planned for 2027. Second quarter 2026 net loss was $4.5 million, compared with $1.9 million a year earlier, driven by higher R&D and G&A expenses as clinical and corporate activities expanded.
www.stocktitan.net
August 12, 2026 at 10:00 AM
#ELOX Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-reports-second-quarter-2026-financial-results-cso3v8va1rvv.html
https://www.stocktitan.net/news/ELOX/eloxx-pharmaceuticals-reports-second-quarter-2026-financial-results-cso3v8va1rvv.html
Eloxx Pharmaceuticals (NASDAQ:ELOX) Issues Quarterly Earnings Results
Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. Eloxx Pharmaceuticals Price Performance ELOX…
Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. Eloxx Pharmaceuticals Price Performance ELOX…
Eloxx Pharmaceuticals (NASDAQ:ELOX) Issues Quarterly Earnings Results
Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. Eloxx Pharmaceuticals Price Performance ELOX stock traded up $2.18 during midday trading on Tuesday, reaching $19.18. The company had a trading volume of 51,268 shares, compared to its average [...]
news-area.com
August 12, 2026 at 10:58 AM
Eloxx Pharmaceuticals (NASDAQ:ELOX) Issues Quarterly Earnings Results
Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. Eloxx Pharmaceuticals Price Performance ELOX…
Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.66) earnings per share (EPS) for the quarter, Zacks reports. Eloxx Pharmaceuticals Price Performance ELOX…
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
https://www.byteseu.com/2268277/
Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the Company’s …
https://www.byteseu.com/2268277/
Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the Company’s …
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - Bytes Europe
ARLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), a clinical-stage biopharmaceutical company developing exaluren for
www.byteseu.com
August 12, 2026 at 10:39 AM
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
https://www.byteseu.com/2268277/
Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the Company’s …
https://www.byteseu.com/2268277/
Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the Company’s …
Wie ist denn das bei diesen dunkel eloxierten Alurahmen der heute üblichen Module? Leitet die Elox-Schicht?
June 17, 2026 at 6:12 PM
Wie ist denn das bei diesen dunkel eloxierten Alurahmen der heute üblichen Module? Leitet die Elox-Schicht?
EloX' neuster Coup 🤭
September 11, 2023 at 1:40 PM
EloX' neuster Coup 🤭
Dass die @hummelfee.bsky.social da Elox draufgeschmuggelt hat is voll fies. 😭
October 17, 2023 at 7:11 AM
Dass die @hummelfee.bsky.social da Elox draufgeschmuggelt hat is voll fies. 😭
oh ja nocj nie gesehn und blau elox wie 90s
March 15, 2025 at 5:59 PM
oh ja nocj nie gesehn und blau elox wie 90s
Ich war dabei!
@uliwickert.bsky.social hat seinen Twitter Account gelöscht!
Es war wie ein angekündigter Suizid!
Gut ist, dass wir bei Champagner gute Gespräche haben.
Jetzt wechseln wir zu Rotwein!
PROOOST!!!
#fu*x EloX
@uliwickert.bsky.social hat seinen Twitter Account gelöscht!
Es war wie ein angekündigter Suizid!
Gut ist, dass wir bei Champagner gute Gespräche haben.
Jetzt wechseln wir zu Rotwein!
PROOOST!!!
#fu*x EloX
October 25, 2023 at 6:05 PM
Ich war dabei!
@uliwickert.bsky.social hat seinen Twitter Account gelöscht!
Es war wie ein angekündigter Suizid!
Gut ist, dass wir bei Champagner gute Gespräche haben.
Jetzt wechseln wir zu Rotwein!
PROOOST!!!
#fu*x EloX
@uliwickert.bsky.social hat seinen Twitter Account gelöscht!
Es war wie ein angekündigter Suizid!
Gut ist, dass wir bei Champagner gute Gespräche haben.
Jetzt wechseln wir zu Rotwein!
PROOOST!!!
#fu*x EloX
ペロペロしながらこっち来るマムシ 251012(2042)
YouTube video by Yoshio Hayashi
youtu.be
February 7, 2026 at 9:58 AM
Like minds! I believe that will occur. Not happy that eloX is deputizing (???) his sketch security.
February 22, 2025 at 5:16 PM
Like minds! I believe that will occur. Not happy that eloX is deputizing (???) his sketch security.
EloX holt den Rechtsextremisten Alex Jones zurück. Irrer move.
December 9, 2023 at 6:15 PM
EloX holt den Rechtsextremisten Alex Jones zurück. Irrer move.